The KDOQI guidelines suggest that iron supplementation should be performed in order to maintain ferritin levels > 200 ng/mL in hemodialysis patients and >100 ng/mL in peritoneal dialysis patients and non-dialysis patients with CKD; in all these categories, the transferrin saturation (TSAT) must be kept above 20%. This evidence concerns the gene TF and chronic kidney disease.